Metrics to compare | 600594 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600594PeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.4x | −4.5x | −0.4x | |
PEG Ratio | 0.20 | 0.08 | 0.00 | |
Price/Book | 1.2x | 2.1x | 2.6x | |
Price / LTM Sales | 1.5x | 3.3x | 3.0x | |
Upside (Analyst Target) | - | 40.4% | 49.1% | |
Fair Value Upside | Unlock | 4.1% | 6.3% | Unlock |
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, dripping pills, and oral solutions in the areas of tumor system, cerebrovascular and cardiovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, gynecological, tonic, oncology, orthopedics, gastroenterology, andrology and urology. The company was founded in 1995 and is based in Guiyang, China.